Introduction {#Sec1}
============

Gynecomastia is characterized by the presence of unilateral or bilateral breast tissue in males. This benign condition accounts for 60% of all disorders of the male breast \[[@CR1], [@CR2]\]. While bilateral gynecomastia is common in the neonatal period, early in puberty, and with increasing age, prepubertal unilateral gynecomastia is a rare condition, with only a few cases in literature \[[@CR3]\]. We report a unique clinical presentation of two boys with prepubertal onset of unilateral gynecomastia and discuss the etiology, workup, and therapeutic intervention.

Case reports {#Sec2}
============

Patient 1 {#Sec3}
---------

An 8-year-old boy presented with a mass beneath his right breast, slowly increasing in size over the past 8 months. The patient complained of tenderness of the breast mass and of being teased extensively for his enlarged breast. Family history was negative for breast malignancies, but positive for prepubertal bilateral gynecomastia in the father, as well as in two of his brothers. They underwent surgical excision at about age seven without evidence of recurrence afterwards. Past medical history revealed attention deficit hyperactivity disorder (ADHD), for which the patient was treated with Methylphenidate 30 mg/day and Melatonin 5 mg/day. No other drugs or dermal applications were used. Physical examination showed a healthy-appearing boy, 136 cm tall (SDS 0), without accelerated growth velocity, weighing 30 kg (SDS 0) with a body mass index (BMI) of 16.2 (SDS 1). Palpation of the right breast revealed a firm mobile mass measuring approximately 8 cm in diameter, with tenderness on deep palpation, Tanner stage III \[[@CR4]\]. The right nipple−areola complex was also enlarged, measuring 1.5 cm compared to 1 cm on the left. There was no history or sign of galactorrhea and there were no physical findings indicating onset of puberty. A summary of all endocrine parameters tested with corresponding results is given in Table [1](#Tab1){ref-type="table"}. All parameters were found to be within normal limits. Ultrasound examination of the right breast showed glandular tissue without cysts or signs of malignancy. Surgery (conducted by HKD and IAH) under general anesthesia consisted of peripheral liposuction (with the 2 mm power-assisted lipoplasty (PAL) liposuction system) and subcutaneous partial resection of the gland, conducted through an infra-areolar incision. The dissected gland specimen measured 2.5 × 1.6 × 0.5 cm and weighed 15 g. The resulting depression was reconstructed by leaving part of the glandular tissue in situ and repositioning it, in order to attain a symmetrical result. Pathologic examination revealed normal glandular breast tissue, without evidence of malignancy. Microscopy of the subcutaneous mastectomy specimen showed fibrotic breast tissue with mammary ducts with epithelial hyperplasia, periductal cellular stroma, and stroma hyperplasia. The concluding diagnosis was florid gynecomastia. Recovery from the surgery was uneventful. At a postoperative clinical evaluation 8 months later, no signs of recent breast development were seen. The patient is currently planned for a minor correction under local anesthesia of a minimal residual areolar swelling. Table 1Endocrinologic findingsEndocrine studyPatient 1Patient 2Normal reference rangeTSH1.01.20.4--4.0 mU/LFT413.512.38--22 pmol/LLH\<0.15\<0.15\<0.15--1.3 U/LFSH0.760.94\<0.15--3.7 U/LEstradiol (E2)\<1030\<30--70 pmol/LEstrone11021065--220 pmol/LTestosterone\<0.020.270.03--0.65 nmol/LhCG\<1.0\<1.0\<1.0 ng/mlProlactine9812880--660 mU/L17OHP0.31.00.2--7.4 nmol/LSHBG12311730--210 nmol/lAndrostenedione\<0.050.650.2--2.4 nmol/LDHEAS\<0.41.180.29--1.90 μmol/lEstrogen receptor19\<10\<20 fmol/mgProgesterone receptor1310\<20 fmol/mg*TSH* thyroid-stimulating hormone, *FT4* free thyroxine, *LH* luteinizing hormone, *FSH* follicle-stimulating hormone, *hCG* human chorionic genodotropin, *17OHP* 17-hydroxy-progesterone, *SHBG* sex hormone-binding globulin, *DHEAS* dehydroepiandrosterone

Patient 2 {#Sec4}
---------

An 11-year-old boy presented with a 12-month history of left breast enlargement. The patient also complained of tenderness of the breast mass and of great inconvenience in everyday life. In this case, there was no family history of breast malignancies or gynecomastia. No drugs or dermal applications were used. Physical examination showed a healthy-appearing lively boy. The patient was 138 cm tall (SDS −1) without accelerated growth velocity, weighing 32 kg (SDS 0) with a BMI of 16.8 (SDS 0). Palpation of the left breast revealed a firm mass measuring approximately 5 cm in diameter, with tenderness on deep palpation, Tanner stage III. There was a pronounced asymmetry of the breast, with a normal-appearing right breast (Fig. [1a](#Fig1){ref-type="fig"}). No history or sign of galactorrhea existed, and there were no physical findings indicating onset of puberty. A summary of all endocrine parameters tested with corresponding results is given in Table [1](#Tab1){ref-type="table"}. All parameters were found to be within normal limits. Ultrasound examination of the right breast showed retro-aureolar glandular tissue with normal aspects and swelling containing subcutaneous fat tissue. An abdominal computed tomography scan excluded any estrogen-producing tumor. Surgery (conducted by HKD) under general anesthesia consisted of peripheral liposuction (with the 2 mm PAL liposuction system) and subcutaneous partial resection of the gland, conducted through an infra-areolar incision. The specimen dissected measured 5.0 × 3.0 × 2.5 cm. Pathologic examination revealed normal glandular breast tissue, without evidence of malignancy. Microscopy of the subcutaneous mastectomy specimen showed mammary ducts with hypertrophic ductuli and mild lymphocytic infiltrates lining the ducts. The concluding diagnosis was normal gynecomastia tissue. Recovery was uneventful. At a postoperative clinical evaluation 11 months later, there were no signs of breast development (Fig. [1b](#Fig1){ref-type="fig"}). Fig. 1**a** An 11-year-old boy with unilateral gynecomastia of his left breast. **b** The same boy at an 11-month postoperative evaluation, without any signs of breast development

Discussion {#Sec5}
==========

Gynecomastia is a condition in which the glandular components of the male breast proliferate, resulting in an enlargement of one or both breasts. In the age distribution, three distinct peaks are identified. The first is found in the neonatal period, in which palpable breast tissue develops in 60% to 90% of all newborns due to transfer of estrogens across the placenta. The second peak occurs during puberty, as a result of an imbalance between estrogens and androgens within the breast tissue. The last peak is found in the adult population, with the highest prevalence among 50- to 80-year-old males \[[@CR1], [@CR3]\]. Common known causes for gynecomastia in adults include liver disease, as well as the use of drugs such as digitalis and tricyclic antidepressants \[[@CR5]\]. In contrast to gynecomastia in adolescent boys and adult men, prepubertal gynecomastia is rare. A specific cause is hardly ever identified, and in 90% of patients, prepubertal gynecomastia is classified as idiopathic \[[@CR2], [@CR6]\]. Known causes of breast enlargement in children are diverse \[[@CR3], [@CR6]--[@CR8]\]. Therefore, further exploration of the etiology is advised, particularly to rule out any endocrine or malignant abnormalities. A variety of endocrinopathies, mostly as a result of an increased ratio of circulating estrogens to androgens, induce stimulation of breast tissue leading to gynecomastia. Calzada et al. showed that the presence of hormone receptors in gynecomastia may provide a setting favorable for mammary glands to develop gynecomastia \[[@CR9]\]. In patient 1, there were low levels of both receptors and, in patient 2, only the progesterone receptor was detected. We conclude that the gynecomastia in our patients was not mediated by an abnormal increase in the numbers of these receptors. The family history of our first patient revealed gynecomastia on the father\'s side. Stratakis et al. described increased extraglandular aromatization of androgens to cause the unusual entity of familial gynecomastia, named aromatase excess syndrome \[[@CR10]\]. This syndrome has been correlated to serum estradiol and estrone excess, which were within normal limits in both of our patients. Therefore, a mild aromatase excess syndrome could be excluded as a cause of the prepubertal gynecomastia and familial occurrence. None of our patients were exposed to exogenous estrogens. However, our first patient was using Melatonin, of which in literature only one case is reported. The case described a possible relationship of the usage of this drug and a painful bilateral gynecomastia in an adult male \[[@CR11]\], making the relationship between this drug and gynecomastia in our first patient very unlikely. Furthermore, obesity is documented in 31% of the boys, with excessive fat tissue as a possible cause of prepubertal gynecomastia \[[@CR3]\]. Increased adipose tissue causes an increased aromatization of mostly testosterone in adipose tissue, leading to an imbalance between estradiol and testosterone levels. Our patients had no signs of being overweight; therefore, obesity was excluded as the etiology for the gynecomastia.

In summary, atypical presentations of gynecomastia are frequently underappreciated, with little attention to breast enlargement in the nonobese prepubertal boy. Since prepubertal gynecomastia could be a sign of possible underlying diseases, a thorough examination and further research is recommended. If a reversible cause can be excluded, peripheral liposuction in combination with surgical resection of the gland tissue by an infra-areolar approach is the first therapy of choice. We report two rare cases of prepubertal unilateral gynecomastia, in whom the cause of the gynecomastia remains unclear, while none of the above discussed causes could be identified.
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